Article info
Original research
Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC
- Correspondence to Dr Sönke Detlefsen, Department of Pathology, Odense University Hospital, Odense 5000, Denmark; sonke.detlefsen{at}rsyd.dk
Citation
Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC
Publication history
- Received March 28, 2020
- Revised April 15, 2020
- Accepted April 16, 2020
- First published May 8, 2020.
Online issue publication
December 11, 2020
Article Versions
- Previous version (8 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.